Ironwood Pharma (IRWD) Linzess Update Incrementally Positive, But Not Likely to Impact Sales - Cowen

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. WMT
6. ADI
7. ROST
8. MRK
9. MRNA
10. COTY

Go back to Ironwood Pharma (IRWD) Linzess Update Incrementally Positive, But Not Likely to Impact Sales - Cowen

Ironwood Pharma (IRWD) Announces Positive Phase III Trial of LINZESS in Patients 6-17 with FC

September 6, 2022 7:01 AM EDT

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) announced positive topline data from a Phase III clinical trial... More